11:32 AM
 | 
Jan 20, 2017
 |  BC Week In Review  |  Company News  |  Deals

APT Therapeutics, AZ deal

The companies partnered to develop APT's APT102. APT will receive an upfront payment and is eligible for development...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >